Document:

EX-10.2

 Exhibit 10.2 
 CONFORMED COPY 
 WebMD Health Corp. 

111 Eighth Avenue 

New York, NY 10001 
 As of
May 7, 2013 
 Peter Anevski 
 c/o
WebMD Health Corp. 
 111 Eighth Avenue 

New York, NY 10001 
 Dear Pete: 

This letter (“Letter Agreement”) sets forth the terms of your continued employment with WebMD Health Corp. (the
“Company” or “WebMD Health”), effective as of May 7, 2013 (“Effective Date”). 
 1.
Position and Responsibilities. Commencing on the Effective Date, May 7, 2013, you will serve in the position of Executive Vice President-Chief Financial Officer. You will report to the Chief Executive Officer or President of WebMD Health
and will assume and discharge such responsibilities as are commensurate with such position as such person may direct. During your employment with the Company, you will devote your full business time to your duties and responsibilities and will
perform them faithfully and diligently in accordance with the terms of this Agreement, subject to permitted absence in accordance with the Company’s vacation policy. In addition, you will continue to comply with and be bound by the operating
policies, procedures and practices of the Company including, without limitation, the Code of Conduct, in effect from time to time during your employment. You will continue to report to the Company’s headquarters located in New York, NY. You
acknowledge that you are required to travel in connection with the performance of your duties but you will not be required to relocate outside the New York metropolitan area without your consent. 

2. Compensation. 
 (a) Effective as of May 7, 2013, your base salary (“Base Salary”) will increase to $425,000 annually, payable in accordance with the Company’s prevailing payroll practices. 

(b)(i) Your aggregate bonus for the year ended December 31, 2012 ($200,000) was structured and payable as follows: (A) $40,000
of the 2012 Bonus was paid in March 2013, and (B) subject to and in accordance with the terms of the Company’s Supplemental Bonus Plan and Section 5 below, an amount equal to $160,000 was contributed into the Supplemental Bonus Trust.

 (ii) You will be eligible for an annual bonus opportunity for the year ended
December 31, 2013 of up to 141% of your base salary (i.e., $600,000) (the “2013 Bonus”), as follows: 
 (A) Up to $300,000 will be payable based upon achievement of the 2013 revenue and earnings targets approved by the Compensation Committee. 

(B) Up to $300,000 will be payable in the sole discretion of the Compensation Committee or its designee. Any 2013 Bonus
will be paid at the time that bonuses are paid to other executives of the Company for the year ended December 31, 2013, but no later than April 15, 2014 (to the extent applicable, such amount to be paid into the Supplemental Bonus Trust),
so long as you are employed on such date, except as set forth in Section 5. 
 (iii) For fiscal years subsequent to the year
ending December 31, 2013, you will be eligible for an annual bonus, the target of which will be 100% of your base salary, but which amount will be determined in the sole discretion of the Compensation Committee or its designee. Subject to
Section 5 below, if your employment is terminated following the end of any fiscal year by the Company without Cause or by you for Good Reason (as defined below), then you will still be entitled to receive any bonus otherwise payable to you for
such year, even if you are not employed on the bonus payment date and such bonus will be paid at the time that bonuses are paid to other executives of the Company. 
 (iv) The determination as to whether the financial goals in Section 2(b)(ii)(A) and the amount of the bonus, if any, payable under Section 2(b)(ii)(B) shall be made by the CEO and Compensation
Committee in their sole discretion. Reasonable adjustments shall be made by the Compensation Committee to the goals in its discretion to reflect the effect of acquisitions/divestitures and any other circumstances. The financial goals in
Section 2(b)(ii)(A) will be the same as those established for other executives of the Company. 
 3. Other Benefits.
You will continue to be entitled to receive the standard employee benefits made available by the Company to its employees to the full extent of your eligibility. You will be entitled to vacation consistent with the Company’s vacation policy,
but in no event less than 4 weeks annually. During your employment, you will be permitted, to the extent eligible, to participate in any group medical, dental, life insurance and disability insurance plans, or similar benefit plan of the Company
that is available to employees generally. Participation in any such plan will be consistent with your rate of compensation to the extent that compensation is a determinative factor with respect to coverage under any such plan. The Company will
reimburse you for all reasonable expenses actually incurred or paid by you in the performance of your services on behalf of the Company, upon prior authorization and approval in accordance with the Company’s expense reimbursement policy as from
time to time in effect. 
 4. WebMD Health Equity. 

(a) On May 8, 2013, (the “2013 First Restricted Stock Grant Date”), you were granted 10,000 shares of restricted stock of
WebMD (the “2013 First Restricted Stock Grant”) under the terms of the Equity Plan. 100% of the 2013 First Restricted Stock Grant shall vest and the 

  
 2 

 
restrictions thereon lapse on the third anniversary of the 2013 First Restricted Stock Grant Date, subject to your continued employment on such date; provided that subject to your continued
employment on May 8, 2014 if the Compensation Committee, in its sole discretion, determine that the financial goals in Section 2(b)(ii)(A) are fully achieved the 2013 First Restricted Stock Grant shall vest and the restrictions thereon
shall lapse on May 8, 2014. In addition, in the event of a termination of your employment by the Company (or its successor) without Cause or by you for Good Reason, in each case, following a Change of Control of WebMD (as defined below), the
shares subject to the 2013 First Restricted Stock Grant shall vest in full and the restrictions thereon shall lapse. The 2013 First Restricted Stock Grant will be evidenced by the Company’s form of restricted stock agreement. 

(b) On May 8, 2013 (the “2013 Second Restricted Stock Grant Date”), you were granted 10,000 shares of restricted stock of
WebMD (the “2013 Second Restricted Stock Grant”) under the terms of the Equity Plan. 100% of the 2013 Second Restricted Stock Grant shall vest and the restrictions thereon lapse on the third anniversary of the 2013 Second Restricted Stock
Grant Date, subject to your continued employment on such date; provided that subject to your continued employment on May 8, 2014 the Compensation Committee, in its sole discretion, may determine that based on your individual performance the
restrictions thereon shall lapse on such date. In addition, in the event of a termination of your employment by the Company (or its successor) without Cause or by you for Good Reason, in each case, following a Change of Control of WebMD (as defined
below), the shares subject to the 2013 Second Restricted Stock Grant shall vest in full and the restrictions thereon shall lapse. The 2013 Second Restricted Stock Grant will be evidenced by the Company’s form of restricted stock agreement.

 (c) On May 8, 2013, you were granted a nonqualified option (the “2013 Options”) to purchase 15,000 shares of
common stock of WebMD Health under the Equity Plan. The per share exercise price is equal to the closing price of the Company’s common stock on the date of grant and the 2013 Options vest subject to your continued employment on the applicable
vesting dates in equal annual installments of 50% commencing on May 8, 2013 (full vesting on May 8, 2015). The 2012 Options have a term of ten years, subject to earlier termination in the event of termination of employment in accordance
with the Equity Plan. The 2012 Options are evidenced by the Company’s form of option agreement. 
 5. Termination of
Employment. (a) In the event of the termination of your employment by the Company without Cause or by you for Good Reason (as such terms are defined on Annex A attached hereto), subject to Section 5(b) below and your continued
compliance with all restrictive covenant agreements to which you are bound, (i) you will continue to receive, as severance, your base salary in effect on the date of such termination for a period of twelve (12) months (the “Severance
Period”); (ii) if such termination occurs after the end of a calendar year subsequent to the year ended December 31, 2013 but before the payment of bonuses for such year, you shall be entitled to the bonus that you would have received
for such year at the time that bonuses are paid to other executive officers of the Company, but in no event later than April 15 of the year in which your employment terminates, and (iii) if you timely elect to continue your health coverage
through COBRA, the Company will pay that portion of the COBRA premium that it would pay if you were an active employee with the same type of coverage through the Severance Period or, if earlier, until you are eligible for comparable

  
 3 

 
coverage with a subsequent employer. In the event of (i) a termination of your employment by the Company (or its successor) without Cause or by you for Good Reason, in each case, following a
Change of Control of WebMD (as defined below), subject to Section 5(b) and your continued compliance with all restrictive covenant agreements to which you are bound, in addition to the payments and benefits set forth above in this
Section 5(a), (i) you shall receive the 2012 Bonus referred to in Section 2(b)(i) above, payable in accordance with the provisions of Section 2(b)(i)(B), and (ii) with respect to any 2013 Bonus referred to in
Section 2(b)(ii) above, you shall receive the greater of (X) $300,000 or (Y) the portion of the 2013 Bonus achieved through the date of termination (to the extent applicable, such amount to be paid from the Supplemental Bonus Trust),
and (iii) the shares subject to the 2013 First Restricted Stock Grant and the 2013 Second Restricted Stock Grant shall vest in full and the restrictions thereon shall lapse. In the event of a termination of your employment by the Company
without Cause or by you for Good Reason, in either case within twelve (12) months following a Change of Control, any of your options to purchase shares of WebMD Health Corp. (whether outstanding on the date hereof or that may be granted in the
future), which remain outstanding at the time of such termination, to the extent unvested, shall remain outstanding and continue to vest as if you remained in the employ of the Company until the first anniversary of such date of termination. In the
event of termination of your employment for any other reason, you will receive compensation earned through the date of termination and your rights with respect to options and restricted stock will be as specified in the applicable option or
restricted stock agreements. The term “Change of Control of WebMD” shall have the meaning ascribed to such term in the Equity Plan. 
 (b) In order to receive any of the benefits described in Section 5(a) under this Letter Agreement (the “Severance Benefits”), you must (i) execute and deliver to the Company a
release of claims satisfactory to the Company (but which will not require release of any Company payments due to you that are otherwise payable at the date of termination of this Letter Agreement) within the time prescribed therein but in no event
later than fifty (50) days of the date of your termination of employment and (ii) not revoke such release pursuant to any revocations rights afforded by law. The Company shall provide to you the form of release no later than three
(3) days following your termination of employment. If you do not timely execute and deliver to the Company such release, or if you execute such release but revoke it, no Severance Benefits shall be paid. 

(c) The Severance Benefits described in Section 5(a)(i) above shall be paid, minus applicable deductions, including deductions for
tax withholding, in equal payments on the regular payroll dates during the one-year period following your termination of employment. Commencement of payments of the Severance Benefits described in Section 5 (a)(i) shall begin on the first
payroll date that occurs in the month that begins at least 60 days after the date of your termination of employment, but which may be accelerated by no more than 30 days (the “Starting Date”) provided that you have satisfied the
requirements of Section 5(b) of this Letter Agreement. The first payment on the payment Starting Date shall include those payments that would have previously been paid if the payments of the Severance Benefits described in Section 5(a)(i)
had begun on the first payroll date following your termination of employment. This timing of the commencement of benefits is subject to Section 6 below. 

  
 4 

 (d) For purposes of this Letter Agreement, “termination of employment” shall mean
a “separation of service” as defined in Section 409A of the Internal Revenue Code of 1986, as amended, (the “Code”) and Treasury Regulations Section 1.409A-I(h) without regard to the optional alternative
definitions available thereunder. 
 (e) All Severance Benefits shall be completed by, and no further Severance Benefits shall be
payable after, December 31 of the second taxable year following the year in which your termination of employment occurs. 

(f) Your entitlement to the payments of the Severance Benefits described in Section 5(a)(i) shall be treated as the entitlement to a
series of separate payments for purposes of Section 409A of the Code. 
 6. Section 409A. 

(a) Potential Six-Month Delay. Notwithstanding any other provisions of the Letter Agreement, any payment of the Severance Benefits
under this Letter Agreement that the Company reasonably determines is subject to Section 409A(a)(2)(B)(i) of the Code shall not be paid or payment commenced until the later of (i) six (6) months after the date of your termination of
employment (or, if earlier, your death) and (ii) the Starting Date. On the earliest date on which such payments can be commenced without violating the requirements of Section 409A(a)(2)(B)(i) of the Code, you shall be paid, in a single
cash lump sum, an amount equal to the aggregate amount of all payments delayed pursuant to the preceding sentence. 
 (b)
Savings Clause. It is intended that any amounts payable under this Letter Agreement shall either be exempt from or comply with Section 409A of the Code (including Treasury regulations and other published guidance related thereto) so as
not to subject you to payment of any additional tax, penalty or interest imposed under Section 409A of the Code. The provisions of this Letter Agreement shall be construed and interpreted to avoid the imputation of any such additional tax,
penalty or interest under Section 409A of the Code yet preserve (to the nearest extent reasonably possible) the intended benefit payable to you. Notwithstanding the foregoing, the Company makes no representation or warranty and shall have no
liability to you or to any other person if any of the provisions of this Letter Agreement are determined to constitute deferred compensation subject to Section 409A, but that do not satisfy an exemption from, or the conditions of, that section.

 7. Restrictive Covenants. As a condition to the effectiveness of this Agreement, you will be required to sign the
attached Trade Secret & Proprietary Information Agreement. 
 8. Conflicting Employment. You agree that, during
your employment with the Company, you will not engage in any other employment, occupation, consulting or other business activity directly related to the business in which the Company is now involved or becomes involved during your employment, nor
will you engage in any other activities that conflict with your obligations to the Company. With the prior written approval of the Company, which will not be unreasonably withheld, you may serve on the Board of Directors of other companies, and
provided that such service does not affect the services to be provided under this Agreement. 

  
 5 

 9. At-Will Employment. You acknowledge that your employment with the Company is for
an unspecified duration that constitutes at-will employment, and that either you or the Company can terminate this relationship at any time, with or without Cause and with or without notice (subject to the consequences set forth in this agreement).

 10. General Provisions. 
  

	 	(a)	You will be covered by the Company’s director and officer insurance policy to the same extent as other similarly situated employees of the Company.

  

	 	(b)	This Letter Agreement and the terms of your employment will be governed by the laws of New York, applicable to agreements made and to be performed entirely within such
state and the courts sitting in New York, New York shall have exclusive jurisdiction for the purposes of adjudicating any disputes under this Agreement. 

  

	 	(c)	This Letter Agreement together with the equity plans and agreements referred to herein and the Trade Secret and Proprietary Agreement attached hereto sets forth the
entire agreement and understanding between the Company and you relating to your employment and supersedes all prior agreements and verbal discussions between us. 

 

	 	(d)	This Letter Agreement will be binding upon your heirs, executors, administrators and other legal representatives and will be for the benefit of the Company and its
permitted successors and assigns. 

  

	 	(e)	All payments pursuant to this Letter Agreement will be subject to applicable withholding taxes. 

 

	 	(f)	This Letter Agreement may not be assigned by you without the Company’s prior written consent; provided however that this agreement may be assigned by the Company
without your prior written consent to any successor to the business of the Company, by operation of law, merger or otherwise or to any affiliate of the Company. 

  
 6 

 Please acknowledge and confirm your acceptance of this amendment and restatement of your
offer letter by signing and returning one copy of this letter agreement and the Trade Secret & Proprietary Information Agreement to Douglas W. Wamsley, Executive Vice President, General Counsel, WebMD Health Corp., 111 Eighth Avenue, New
York, NY 10001. 
  

			
	WebMD Health Corp.
		
	By	 	/s/ Douglas W. Wamsley
		 	Douglas W. Wamsley

 ACCEPTANCE: 
 I accept the revised terms of my continued employment with WebMD Health Corp. as set forth herein. I understand that this letter agreement does not constitute a contract of employment for any specified
period of time, and that either party, with or without Cause and with or without notice, may terminate my employment relationship (subject to the consequences set forth above). 

 

	
	/s/ Peter Anevski
	Peter Anevski
	
	August 8, 2013
	Date Signed

  
 7 

 ANNEX A 
 “Cause” will mean any of the following: 
 (i) your willful failure
to perform your duties following written notice from the Company detailing the specific acts and a thirty (30) day period of time to remedy such failure; 
 (ii) any willful misconduct, violence or threat of violence that is injurious to the Company in a material respect or any misconduct relating to your business affairs, at any time, which will demonstrably
reflect negatively upon the Company or otherwise impair or impede its operations or reputation in any material respect; 
 (iii)
your breach of a material Company policy, which breach is not remedied (if susceptible to remedy) following written notice by the Company detailing the specific breach and a thirty (30) day period of time to remedy such breach; 

(iv) any material breach by you of this Agreement or the Trade Secret and Proprietary Information Agreement, which breach is not remedied
(if susceptible to remedy) following written notice by the Company or its designee detailing the specific breach and a thirty (30) day period of time to remedy such breach; 

(v) your conviction of a felony in respect of a dishonest or fraudulent act or other crime of moral turpitude. 

“A termination of employment by you for “Good Reason” means your resignation of employment within one year of the
occurrence (without your written consent) of any of the following conditions or events: (i) any material reduction in your base salary, (ii) a material reduction in your authority with the Company, (iii) any material breach by the
Company of this Letter Agreement; provided, however, that none of the foregoing conditions or events shall constitute Good Reason unless (A) you shall have provided written notice to the Company within ninety (90) days after the occurrence
of such condition or event describing the condition or event claimed to constitute Good Reason and (B) the Company shall have failed to remedy the condition or event within thirty (30) days of its receipt of such written notice.

 ANNEX B 
 TRADE SECRET AND PROPRIETARY INFORMATION AGREEMENT 
 In consideration of my employment with
WebMD LLC and/or any of its corporate parents, subsidiaries, divisions, or affiliates, or the successors or assigns of any of the foregoing (hereinafter referred to as the “Company”), I hereby agree as follows: 

 

	1.	Confidentiality. 

  

	 	a)	Trade Secret and Proprietary Information. I understand and acknowledge that, during the course of my employment with the Company and as a result of my
having executed this Restrictive Covenant Agreement (“Agreement”), I will be granted access to valuable information relating to the business of the Company that provides the Company with a competitive advantage (or that could be used to
the disadvantage of the Company by a Competitive Business) (as defined herein), which is not generally known by, nor easily learned or determined by, persons outside the Company (collectively “Trade Secret and Proprietary
Information”). The term “Trade Secret and Proprietary Information” shall include, but shall not be limited to: (a) specifications, manuals, software in various stages of development; (b) customer and prospect lists, and
details of agreements and communications with customers and prospects; (c) sales plans and projections, product pricing information, acquisition, expansion, marketing, financial and other business information and existing and future products
and business plans of the Company; (d) sales proposals, demonstrations systems, sales material; (e) research and development; (f) computer programs; (g) sources of supply; (h) identity of specialized consultants and
contractors and Trade Secret and Proprietary Information developed by them for the Company; (i) purchasing, operating and other cost data; (j) special customer needs, cost and pricing data; (k) employee information (including, but not
limited to, personnel, payroll, compensation and benefit data and plans); and (l) patient information, including without limitation Protected Health Information as defined in 45 C.F.R. 164.50, including all such information recorded in manuals,
memoranda, projections, reports, minutes, plans, drawings, sketches, designs, formula books, data, specifications, software programs and records, whether or not legended or otherwise identified by the Company as Trade Secret and Proprietary
Information, as well as such information that is the subject of meetings and discussions and not recorded. Trade Secret and Proprietary Information shall not include such information that I can demonstrate (i) is generally available to the
public (other than as a result of a disclosure by me), (ii) was disclosed to me by a third party under no obligation to keep such information confidential or (iii) was known by me prior to, and not as a result of, my employment or
anticipated employment with the Company. 

  

	 	b)	Duty of Confidentiality. I agree at all times, both during and after my employment with the Company, to hold all of the Trade Secret and Proprietary
Information in a fiduciary capacity for the benefit of the Company and to safeguard all such Trade Secret and Proprietary Information. I also agree that I will not directly or indirectly disclose or use any such Trade Secret and Proprietary
Information to any third person or entity outside the Company, except as may be necessary in the good faith performance of my duties for the Company. I further agree that, in addition to enforcing this restriction, the Company may have other
rights and remedies under the common law or applicable statutory laws relating to the protection of trade secrets. Notwithstanding anything in this Agreement to the contrary, I understand that I may disclose the Trade Secret and Proprietary
Information to the extent required by applicable laws or governmental regulations or judicial or regulatory process, provided that I give the Company prompt notice of any and all such requests for disclosure so that it has ample opportunity to take
all necessary or desired action, to avoid disclosure. 

	 	c)	Company Property. I acknowledge that: (i) all Trade Secret and Proprietary Information of the Company, (ii) computers, and computer-related
hardware and software, cell phones, beepers and any other equipment provided to me by the Company, and (iii) all documents I create or receive in connection with my employment with the Company, belong to the Company, and not to me personally
(collectively, “Company Property”). Such documents include, without limitation and by way of non-exhaustive example only: papers, files, memoranda, notes, correspondence, lists, e-mails, reports, records, data, research, proposals,
specifications, models, flow charts, schematics, tapes, printouts, designs, graphics, drawings, photographs, abstracts, summaries, charts, graphs, notebooks, investor lists, customer/client lists, and all other compilations of information,
regardless of how such information may be recorded and whether in printed form or on a computer or magnetic disk or in any other medium. I agree to return all Company Property (including all copies) to the Company immediately upon any
termination of my employment, and further agree that, during and after my employment with the Company, I will not, under any circumstances, without the Company’s specific written authorization in each instance, directly or indirectly disclose
Company Property or any information contained in Company Property to anyone outside the Company, or otherwise use Company Property for any purpose other than the advancement of the Company’s interests. 

 

	 	d)	Unfair Competition. I acknowledge that the Company has a compelling business interest in preventing unfair competition stemming from the intentional or
inadvertent use or disclosure of the Company’s Trade Secret and Proprietary Information and Company Property. 

  

	 	e)	Investors, Other Third-Parties, and Goodwill. I acknowledge that all third-parties (e.g., customers, vendors, and advertisers) I service or propose to
service while employed by the Company are doing business with the Company and not me personally, and that, in the course of dealing with such third-parties, the Company establishes goodwill with respect to each such third-party that is created and
maintained at the Company’s expense (“Third-Party Goodwill”). I also acknowledge that, by virtue of my employment with the Company, I have gained or will gain knowledge of the business needs of, and other information concerning,
third-parties, and that if such information were used to solicit or service any such third-parties on my own behalf or on behalf of a Competitive Business (as defined herein), the Company would be competitively disadvantaged.

  

	 	f)	 Intellectual Property and Inventions. I acknowledge that all developments, including, without limitation, the creation of new products,
conferences, training/seminars, publications, programs, methods of organizing information, inventions, discoveries, concepts, ideas, improvements, patents, trademarks, trade names, copyrights, trade secrets, designs, works, reports, computer
software, flow charts, diagrams, procedures, data, documentation, and writings and applications thereof relating to the past, present, or future business of the Company that I, alone or jointly with others, may have discovered, conceived, created,
made, developed, reduced to practice, or acquired during my employment with the Company (collectively, “Developments”) are works made for hire and shall remain the sole and exclusive property of the Company, and I hereby assign to the
Company all of my rights, titles, and interest in and to all such Developments, if any. I agree to disclose to the Company promptly and fully all future Developments and, at any time upon request and at the expense of the Company, to execute,
acknowledge, and deliver to the Company all instruments that the Company shall prepare, to give evidence, and to take any 

  
 B-2

	 	
and all other actions that are necessary or desirable in the reasonable opinion of the Company to enable the Company to file and prosecute applications for, and to acquire, maintain, and enforce,
all letters patent, trademark registrations, or copyrights covering the Developments in all countries in which the same are deemed necessary by the Company. All data, memoranda, notes, lists, drawings, records, files, investor and
client/customer lists, supplier lists, and other documentation (and all copies thereof) made or compiled by me or made available to me concerning the Developments or otherwise concerning the past, present, or planned business of the Company are
Company Property, and will be delivered to the Company immediately upon the termination of my employment with the Company. 

  

	2.	Covenant Not to Compete with the Company. 

  

	 	a)	I acknowledge that the business of the Company can be conducted anywhere in the world and is not limited to a geographic scope or region, that its products, programs
and services are marketed throughout the United States, Canada and other geographic regions throughout the world, that the Company competes in nearly all of its business activities with other individuals or entities that are, or could be, located in
nearly any part of the world and that the nature of my services, position, and expertise are such that I am capable of competing with the Company from nearly any location in the world. 

 

	 	b)	Accordingly, in order to protect the Company’s Trade Secret and Proprietary Information and Third-Party Goodwill, I acknowledge and agree that during my employment
with the Company and for a period of one year after the date my employment with the Company is terminated for any reason (the “Restricted Period”), I will not, without the Company’s express written permission, directly or indirectly
(including through the Internet), own, control, manage, operate, participate in, be employed by, or act for or on behalf of (as principal, agent, employee, consultant, director or otherwise), any “Competitive Business” (as defined
herein) located anywhere within the geographic boundaries of the United States, Canada and the world. 

  

	 	c)	For purposes of this Agreement “Competitive Business” will mean: (i) any enterprise engaged in developing, selling or providing (via the internet or
other means) health or wellness information, decision support tools or services or applications and/or communication services, directly or indirectly, to consumers, health and/or benefit plan members or employees or healthcare professionals,
including but not limited to products or services that provide information on diseases, conditions or treatments, store health care information, assess personal health status, and/or assist in making informed benefit, provider or treatment choices;
and (ii) any enterprise engaged in any other type of business in which the Company is also engaged, or plans to be engaged, so long as I am directly involved in such business or planned business on behalf of the Company. Notwithstanding
the foregoing, I understand that I may have an interest consisting of publicly traded securities constituting less than 1 percent of any class of publicly traded securities in any public company engaged in a Competitive Business, so long as I am not
employed by, do not consult with, or become a director of or otherwise engage in any activities for, such company. 

  

	3.	Non-Solicitation of Employees, Customers. In order to protect the Company’s Trade Secret and Proprietary Information and Third-Party Goodwill, during
the Restricted Period, I will not, without the Company’s express written permission, directly or indirectly: 

  
 B-3

	 	a)	solicit, induce, hire, engage, or attempt to hire or engage any employee or independent contractor of the Company, or in any other way interfere with the
Company’s employment or contractual relations with any of its employees or independent contractors, nor will I solicit, induce, hire, engage or attempt to hire or engage any individual who was an employee of the Company at any time during
the one (1) year period immediately prior to the termination of my employment with the Company; and 

  

	 	b)	contact, call upon, encourage or solicit, on behalf of a Competitive Business, any existing or prospective client, or customer of the Company who I serviced, or
otherwise developed a relationship with, or about whom I obtained confidential information as a result of my employment with the Company, nor will I attempt to divert or take away from the Company the business of any such client or customer.

  

	4.	Injunctive Remedies. I acknowledge and agree that the restrictions contained in this Agreement are reasonably necessary to protect the legitimate business
interests of the Company, and that any violation of any of the restrictions will result in immediate and irreparable injury to the Company for which monetary damages will not be an adequate remedy. I further acknowledge and agree that if any
such restriction is violated, the Company will be entitled to immediate relief enjoining such violation (including, without limitation, temporary and permanent injunctions, a decree for specific performance, and an equitable accounting of earnings,
profits, and other benefits arising from such violation) in any court having jurisdiction over such claim. I also agree that any request for such relief by the Company shall be in addition to, and without prejudice to, any claim for monetary damages
that the Company may elect to assert.

  

	5.	Severability Provision. I acknowledge and agree that the restrictions imposed upon me by the terms, conditions, and provisions of this Agreement are fair,
reasonable, and reasonably required for the protection of the Company. In the event that any part of this Agreement is deemed invalid, illegal, or unenforceable, all other terms, conditions, and provisions of this Agreement shall nevertheless
remain in full force and effect. In the event that the provisions of any of Sections 1, 2, or 3 of this Agreement relating to the geographic area of restriction, the length of restriction or the scope of restriction shall be deemed to exceed
the maximum area, length or scope that a court of competent jurisdiction would deem enforceable, said area, length or scope shall, for purposes of this Agreement, be deemed to be the maximum area, length of time or scope that such court would deem
valid and enforceable, and that such court has the authority under this Agreement to rewrite (or “blue-pencil”) the restriction(s) at-issue to achieve this intent. 

 

	6.	Non-Waiver. Any waiver by the Company of my breach of any term, condition, or provision of this Agreement shall not operate or be construed as a waiver of
the Company’s rights upon any subsequent breach. 

  

	7.	Waiver of Jury Trial. TO THE MAXIMUM EXTENT PERMITTED BY LAW, I HEREBY KNOWINGLY, VOLUNTARILY, AND INTENTIONALLY WAIVE THE RIGHT TO A TRIAL BY JURY IN
CONNECTION WITH ANY LITIGATION ARISING OUT OF, UNDER, IN CONNECTION WITH, OR IN ANY WAY RELATED TO THIS AGREEMENT. THIS INCLUDES, WITHOUT LIMITATION, ANY LITIGATION CONCERNING ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENT (WHETHER VERBAL
OR WRITTEN), OR ACTION OF THE COMPANY OR ME, OR ANY EXERCISE BY THE COMPANY OR ME OF OUR RESPECTIVE RIGHTS UNDER THIS AGREEMENT OR IN ANY WAY RELATING TO THIS AGREEMENT. I FURTHER ACKNOWLEDGE THAT THIS WAIVER IS A MATERIAL INDUCEMENT FOR THE
COMPANY TO ISSUE AND ACCEPT THIS AGREEMENT. 

  
 B-4

	8.	Notice to Future Employers. For a period of two (2) years after my employment with the Company ends, I will inform each new employer, prior to
accepting employment, of the existence and details of the covenants contained in this Annex A and will provide each such employer with a copy of this Annex. 

 

	9.	Assignment. The Company shall have the right to assign its rights and obligations under this Annex A without my consent. I acknowledge that I may not
assign my obligations herein. 

 RESTRICTIVE COVENANT AGREEMENT ACCEPTANCE 

I understand and accept the restrictions and obligations imposed upon me by the terms, conditions, and provisions set forth in this
Restrictive Covenant Agreement and agree to abide by same. 
 /s/ Peter Anevski
                            Date:
8/8/13                     
 Pete
Anevski 

  
 B-5EX-10.3

 Exhibit 10.3 
 CONFORMED COPY 
 WEBMD HEALTH CORP. 

111 Eighth Avenue 
 New York, New York 10011 
 May 7, 2013 

Mr. Cavan Redmond 
 c/o WebMD Health Corp.

 111 Eighth Avenue 
 New York, New
York 10011 
 Dear Cavan: 
 As
discussed, this letter agreement (this “Agreement”) sets forth the terms of your departure from WebMD Health Corp., a Delaware corporation (the “Company”). 

1. Termination. Your employment with the Company and its subsidiaries and affiliates terminated without Cause in all capacities as
of May 6, 2013 (the “Departure Date”). You acknowledge that whether or not you execute this Agreement, pursuant to your employment agreement, dated as of May 29, 2012 (the “Employment Agreement”), you have
resigned your positions as Chief Executive Officer and President and a director of the Company, and from any other officer positions, directorships and positions that you currently hold with the Company or its subsidiaries or affiliates as of the
Departure Date. The Company and its subsidiaries and affiliates have accepted such resignations and, except as otherwise provided under this Agreement, from and after the Departure Date, you are relieved and shall have no further obligation to
either perform any duties or responsibilities or render any services for or on behalf of the Company or its subsidiaries or affiliates whether under Section 1 of the Employment Agreement or otherwise. 

2. Severance Benefits. Subject to your execution of this Agreement, including your delivery and non-revocation of the Release set
forth on Exhibit A (the effective date of the release is hereinafter referred to as the “Effective Date”), the Company will provide you with the following severance payments and benefits: 

(a) Severance. The Company will pay you as severance your base salary at the current annual rate of $650,000.00 (the “Base
Salary”) for a period of two years commencing on the Departure Date (the “Applicable Period”). Subject to your continued compliance with the Release Agreement and Sections 6, 7, 8 and 9 of this Agreement, the Base Salary
will continue to be paid during the Applicable Period pursuant to the Company’s normal payroll practices. The Company acknowledges that the sign-on bonus referred to in Section 2(c) of the Employment Agreement is not repayable by you.

 (b) Reimbursement of Certain Benefits. You acknowledge that you have not been a
participant in the Company’s health plan while employed by the Company and therefore you are not eligible for continuation of such benefits pursuant to the Consolidated Omnibus Reconciliation Act of 1985, as amended (“COBRA”),.
Subject to your execution of this Agreement and continued compliance with the Release Agreement and Sections 6, 7, 8 and 9 of this Agreement, the Company will reimburse you the lesser of (i) the portion of the COBRA premium for which you were
responsible under your prior employer’s plan and (ii) the COBRA premium you would have paid if you were covered under the Company’s health plan. Such reimbursement shall be paid for a period of eighteen (18) months from the
Departure Date, or, if earlier, until such time as you are no longer eligible for COBRA or are otherwise eligible for comparable coverage with a subsequent employer, which reimbursement shall be made within 30 days after you provide evidence of your
payment of such premiums, which evidence shall be provided no later than 30 days after payment. You shall promptly notify the Company if you become eligible for comparable coverage with another employer. 

(c) Company Stock Options. With respect to your option grant dated May 31, 2012, subject to your continued compliance with
the Release Agreement and Sections 6, 7, 8 and 9 of this Agreement, your options to purchase (i) 250,000 shares of the Company’s common stock (the “Common Stock”) that are scheduled to vest on May 31, 2013 and
(ii) 250,000 shares that are scheduled to vest on May 31, 2014, respectively, will vest on May 31, 2013 and May 31, 2014, respectively, as if you had remained employed with the Company through May 31, 2014, and the
post-termination exercise period will begin on May 31, 2014. The remaining two installments, each covering 250,000 shares, shall be forfeited as of the Departure Date. 
 (d) Restricted Stock. Subject to your continued compliance with the Release Agreement and Sections 6, 7, 8 and 9 of this Agreement, 11,250 shares of restricted Common Stock that are scheduled to
vest, respectively, on each of May 31, 2013 and May 31, 2014 shall be deemed vested on the Effective Date. The remaining two installments shall be forfeited as of the Departure Date. 

3. Accrued Salary and Vacation; Expenses. (a) Accrued Salary and Vacation. All your accrued but unpaid Base Salary as
of the Departure Date will be paid to you promptly in accordance with applicable law, and your accrued but unused vacation as of the Departure Date, as reflected in the Company’s time off reporting system, will be paid to you in accordance with
applicable law and the Company’s vacation policy. You are entitled to these amounts (less all applicable withholding and other authorized deductions) whether or not you sign this Agreement. 

(b) Expense Reimbursements. You agree that, within thirty (30) days of the Departure Date, you will submit your final
documented expense reimbursement statement reflecting all business expenses you incurred through your last day of active employment, if any, for which you seek reimbursement. 

  
 2 

 4. Retirement Plan. You will be entitled to receive your vested, accrued benefits
under the Company’s 401(k) plan in accordance with the terms and conditions of such plan. 
 5. No Other Compensation or
Benefits. Except as otherwise specifically provided herein, you will not be entitled to any compensation or benefits or to participate in any past, present or future employee benefit programs or arrangements of the Company or its subsidiaries or
affiliates on or after the Departure Date. 
 6. Covenants and Agreements. The provisions of (i) the Trade Secret
and Proprietary Information Agreement that is attached as Annex A of the Employment Agreement, and (ii) all other agreements you have signed containing covenants regarding non-disclosure of confidential/proprietary information and/or
restrictions on solicitation or competition, including those annexed as part of an equity agreement or compensation plan (collectively, the “Restrictions”) shall remain in full force and effect and shall govern all periods prior to
and following the Effective Date. 
 7. Cooperation. From and after the date hereof, you will (i) cooperate in all
reasonable respects (after taking into account any employment obligations you may have) with the Company, its subsidiaries and affiliates and its directors, officers, attorneys and experts in connection with the conduct of any action, proceeding,
investigation or litigation involving the Company, or any of its subsidiaries or affiliates, including any such action, proceeding, investigation or litigation in which you are called to testify and (ii) promptly respond to all reasonable
requests by the Company and its subsidiaries and affiliates relating to the business, including providing information concerning actual or prospective customers of the Company or any subsidiary or affiliate that may be in your possession. If you
receive a subpoena or other request for information, you agree to provide the Company with prompt notice of the subpoena or request so that the Company may take appropriate action to avoid or contest disclosure. The Company shall reimburse your
reasonable, documented out-of-pocket expenses incident to providing such cooperation or response. Nothing contained in this Agreement (specifically including, without limitation, the provisions of this Section 7 or Section 9 of this
Agreement) shall prohibit or restrict you from participating in a governmental investigation or from providing truthful information in response to any lawfully issued subpoena, or an inquiry or investigation conducted by a governmental or regulatory
agency. 
 8. Return of Property. You represent that you have surrendered to the Company all property of the Company and
its subsidiaries and affiliates in your possession and all property made available to you in connection with your employment by the Company, including, without limitation, any and all records, manuals, customer lists, notebooks, computers, phones,
PDAs, computer programs and files, papers, electronically stored information and documents (and all copies thereof) kept or made by you in connection with your employment. 
 9. Non-disparagement. You agree to refrain from making, directly or indirectly, now or at any time in the future: (i) any derogatory comment concerning the Company, or its subsidiaries and
affiliates or any of its officers, employees, directors and agents, or (ii) any other comment that could reasonably be expected to be detrimental to the business or 

  
 3 

 
financial prospects of the Company or any of its subsidiaries and affiliates, to any third person including, but not limited to: (x) the news or other media, (y) any employees of the
Company, or its subsidiaries or affiliates, or (z) any individual or entity with whom the Company, or any of its subsidiaries or affiliates has or may reasonably expect to have a business relationship. Notwithstanding the foregoing, you shall
be permitted to testify truthfully in any court action or proceeding, including any court action or proceeding to enforce the terms of this Agreement. 
 10. Remedies. You agree that a breach of any of the covenants contained in this Agreement or the Release Agreement will result in material and irreparable injury to the Company for which there is
no adequate remedy at law, that it may not be possible to measure damages for such injuries precisely and that, in the event of such a breach or threat thereof, the Company shall be entitled to seek a temporary restraining order or a preliminary or
permanent injunction, or both, without bond or other security, restraining you from engaging in activities prohibited by the covenants contained in this Agreement or the Release Agreement or such other relief as may be required specifically to
enforce any of the covenants contained in this Agreement or the Release Agreement. In the event of any breach by you of any provision of Section 6, 7, 8 or 9 of this Agreement or the Release Agreement, in addition to any other remedy available
to the Company, the Company (i) shall cease to have any obligation to continue to make payments or provide benefits to you under this Agreement, (ii) may recoup any of the compensation paid under Section 2 hereunder, including,
without limitation, equity compensation and option profit and (iii) you shall be responsible for the reasonable attorneys’ fees and costs related to the Company’s enforcement of such provisions. 

11. Miscellaneous. 
 (a) Entire Agreement. This Agreement, the Release Agreement, Annex A to the Employment Agreement and any other Restrictions, the Indemnity Agreement (as defined below) and the applicable equity
plans and agreements set forth the entire agreement and understanding of the parties hereto with respect to the matters covered hereby and supersede and replace any express or implied prior agreement with respect to the terms of your employment and
the termination thereof which you may have had with the Company or its subsidiaries or affiliates (including, without limitation, the Employment Agreement except as specifically provided in this Agreement). This Agreement may be amended only by a
written document signed by the parties hereto. 
 (b) Governing Law; Consent to Jurisdiction/Venue. This Agreement shall
be governed by and construed for all purposes according to the laws and public policy of the State of New York, as such laws are applied to agreements entered into and to be performed entirely within New York between New York residents and without
regard to principles of conflicts of laws. The parties further agree that any disputes or controversies arising out of or relating to this Agreement shall be brought in the federal or state courts located in New York, New York. The language of this
Agreement shall be construed as a whole according to its fair meaning and not strictly for or against any of the parties. 
 (c)
Withholding. Any payments made or benefits provided to you under this Agreement will be reduced by all applicable withholding taxes and other authorized deductions. 

  
 4 

 (d) No Trust Created. This Agreement constitutes an unfunded promise of the Company
to pay the benefits provided herein and will only be paid from the general assets of the Company. 
 (e) Voluntary
Assent. You affirm that you have read this Agreement and the Release Agreement, and understand all of the terms, including the full and final release of claims set forth in the Release Agreement. You further acknowledge that you have voluntarily
entered into this Agreement and the Release Agreement; that you have not relied upon any representation or statement, written or oral, not set forth in this Agreement or the Release Agreement; that the only consideration for signing this Agreement
and the Release Agreement is as set forth herein; and that this document gives you the opportunity and encourages you to have this Agreement and the Release Agreement reviewed by your attorney and/or tax advisor. 

(f) Section 409A of the Code. It is intended that this Agreement comply with the provisions of Section 409A of the
Internal Revenue Code of 1986, as amended (the “Code”), and the Treasury regulations relating thereto, or an exemption to Section 409A of the Code, and it will be considered and interpreted in accordance with that intent. Any
payments that qualify for the “separation pay” or “short-term deferral” exception or another exception under Section 409A of the Code shall be paid under the applicable exception. For purposes of the limitations on
nonqualified deferred compensation under Section 409A of the Code, each payment of compensation under this Agreement shall be treated as a separate payment of compensation. Despite any contrary provision of this Agreement, any references to
“termination of employment” or the “date of termination” (or any similar term) shall mean and refer to the date of your “separation from service,” as that term is defined in Section 409A of the Code and Treasury
Regulation Section 1.409A-1(h). In no event may you directly or indirectly designate the calendar year of any payment under this Agreement. 
 (g) Waiver. The failure of any party to this Agreement or the Release Agreement to enforce any of the terms, provisions or covenants contained therein shall not be construed as a waiver of the same
or of the right of such party to enforce the same. Waiver by any party hereto of any breach or default by another party of any term or provision of this Agreement or the Release Agreement shall not operate as a waiver of any other breach or default.

 (h) Severability. In the event that any one or more of the provisions of this Agreement shall be held to be invalid,
illegal or unenforceable, the validity, legality and enforceability of the remainder of the Agreement shall not in any way be affected or impaired thereby. Moreover, if any one or more of the provisions contained in this Agreement shall be held to
be excessively broad as to duration, activity or subject, such provisions shall be construed by limiting and reducing them so as to be enforceable to the maximum extent allowed by applicable law. 

(i) Descriptive Headings. The paragraph headings contained herein and in the Release Agreement are for reference purposes only and
shall not in any way affect the meaning or interpretation of this Agreement or the Release Agreement. 

  
 5 

 (j) Notices. Any notices required or made pursuant to this Agreement or the Release
Agreement will be in writing and will be deemed to have been given when delivered or mailed by United States certified mail, return receipt requested, postage prepaid, as follows: Cavan Redmond: at the last home address in the Company’s
records; and 
 if to the Company: 

WebMD Health Corp. 
 111 Eighth Avenue

 New York, NY 10011 
 Attention:
General Counsel 
 or to such other address as either party may furnish to the other in writing in accordance with this Section 11(k).
Notices of change of address will be effective only upon receipt. 
 (k) Indemnification. T he Company shall provide you
with those indemnification rights and benefits provided to you as an officer and director of the Company pursuant to the Indemnity Agreement by and between you and the Company, dated June 1, 2012 (the “Indemnity Agreement”).

 (l) Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same instrument. 
 IN WITNESS WHEREOF, the parties hereto have
executed this Agreement as of the date first written above. 
  

			
	WEBMD HEALTH CORP.
		
	By:	 	/s/ Douglas W. Wamsley
		 	Name: Douglas W. Wamsley
		 	 Title:   Executive Vice President,
             General Counsel and Secretary

  

	
	Accepted and Agreed:
	
	/s/ Cavan M. Redmond
	Cavan Redmond

 Dated: May 7, 2013 

  
 6 

 EXHIBIT A 
 Release 
 This Release Agreement (this “Release Agreement”) is dated as of
May 7, 2013 in connection with the termination of your employment with the Company. 
 1. General Release.

 (a) In consideration for the receipt of those payments that are in excess of the amount required to be paid to you by
applicable law (as detailed in the settlement of account attached hereto), you, on behalf of yourself and your family, agents, representatives, heirs, executors, trustees, administrators, attorneys, successors and assigns (the
“Releasors”), hereby irrevocably and unconditionally (i) represent and warrant that you have received in a timely manner full and complete payment of all amounts due to you under your employment arrangements with the Company or under
any applicable law and/or in connection with the termination of your employment, both at law and pursuant to the terms of the employment arrangements and (ii) release, settle, cancel, acquit, discharge and acknowledge to be fully satisfied, and
covenant not to sue the Company and each of its respective past and/or present subsidiaries, affiliates, successors and assigns, and each of their respective predecessors, and past and/or present stockholders, partners, members, directors, managers,
officers, employees, agents or other representatives, and employee benefit plans of the Company or its affiliates, including, but not limited to, trustees and administrators of these plans, in each case, in their individual and/or representative
capacities (collectively, the “Releasees”) from any and all claims, contractual or otherwise, demands, costs, rights, causes of action, charges, debts, liens, promises, obligations, complaints, losses, damages and all liability of whatever
kind and nature, whether known or unknown, and hereby waive any and all rights that he, she or it may have, from the beginning of time up to and including the time of signing this Release Agreement, or that otherwise may exist or may arise in
respect of your employment or separation from employment with the Company, or is any way connected with or related to any applicable compensatory or benefit plan, program, policy or arrangement, including, but not limited to, any claims relating to
salaries, benefits, bonuses, compensation, fringe benefits, social benefits according to any law or agreement, amounts of director’s insurance, pension fund, provident fund and education fund, overtime, severance pay, sick pay, recreation
payments, vacation payments, prior notice payments, options or other securities, reimbursement of expenses and/or any other payments or benefits due to you by any of the Releasees, as well as any claims arising under any United States federal, state
or local laws, including, but not limited to, any and all claims under Title VII of the Civil Rights Act of 1964, as amended, the Civil Rights Act of 1991, as amended, the Age Discrimination in Employment Act of 1967, as amended, the Older Workers
Benefit Protection Act of 1990, the Equal Pay Act, the Americans with Disabilities Act of 1990, as amended, the Family and Medical Leave Act of 1993, the Employee Retirement Income Security Act of 1974, as amended, and any and all other United
States federal, state or local regulations, ordinances or public policies, any common law or equity claims, or claims under any policy, agreement, understanding or promise, written or oral, formal or informal, between the Company and any of its
affiliates and yourself, now or hereafter recognized, including claims for wrongful discharge, 

  
 A-1

 
slander and defamation, as well as all claims for counsel fees and costs; provided, that such released claims shall not include any claims to enforce your rights under, or with respect to, any
post-termination obligations of the Company expressly undertaken by the Company under your employment arrangements with the Company. 
 (b) The Releasors agree not to bring any action, suit or proceeding whatsoever (including the initiation of governmental proceedings or investigations of any type) against any of the Releasees hereto for
any matter or circumstance concerning which the Releasors have released the Releasees under this Release Agreement. Further, the Releasors agree not to encourage any other person or suggest to any other person that he, she or it institute any legal
action against the Releasees, and you hereby declare, confirm and undertake that, if the Releasors or anyone else in their name should deliver a claim as mentioned above you shall reimburse the Releasees and anyone else on their behalf to the full
extent of the sum of the legal expenses and legal fees incurred by them as a result of any such claim; and in the event that Releasors prevail in such legal action , then the Releasees shall reimburse such sum to the you or the Releasors.
Notwithstanding the forgoing, this Release Agreement is not intended to interfere with your right to file a charge with the Equal Employment Opportunity Commission in connection with any claim you believe you may have against the Company. The
Releasors hereby agree to waive the right to any relief (monetary or otherwise) in any action, suit or proceeding you may bring in violation of this Release Agreement, including any proceeding before the Equal Employment Opportunity Commission or
any other similar body or in any proceeding brought by the Equal Employment Opportunity Commission or any other similar body on your behalf. 
 2. Legal Advice; Reliance. You represent and acknowledge that (a) you have been given adequate time (at least twenty-one (21) days) to consider this Release Agreement (which, by signing
this Release Agreement prior to the expiration of such period, you have expressly agreed to waive) and have been advised to discuss all aspects of this Release Agreement with your private attorney, (b) you have carefully read and fully
understand all the provisions of this Release Agreement, (c) you have voluntarily entered into this Release Agreement, without duress or coercion, and (d) you have not heretofore assigned or transferred or purported to assign or transfer,
to any person or entity, any of the claims described in Section 1(a), any portion thereof or any interest therein. You understand that if you request additional time to review the terms of this Release Agreement, a reasonable extension of time
will be granted. 
 3. Miscellaneous. 
 (a) No Violation of Law. You agree and acknowledge that this Release Agreement is not and shall not be construed to be an admission by the Company of any violation of any United States federal,
state or local statute, ordinance or regulation, or of any duty owed by the Company to you. 
 (b) Governing Law; Consent to
Jurisdiction/Venue. This Release Agreement shall be governed by and construed for all purposes according to the laws and public policy of the State of New York, as such laws are applied to agreements entered into and to be performed

  
 A-2

 
entirely within New York between New York residents and without regard to principles of conflicts of laws. The parties further agree that any disputes or controversies arising out of or relating
to this Release Agreement shall be brought in the federal or state courts located in New York, New York. The language of this Agreement shall be construed as a whole according to its fair meaning and not strictly for or against any of the parties.

 (c) Revocation. You may revoke this Release Agreement within seven (7) days after the date on which you sign this
Release Agreement. You understand that this Release Agreement is not binding or enforceable until such seven (7) day period has expired. Any such revocation must be made in a signed letter executed by you and received by the Company at its
headquarters no later than 5:00 p.m., New York time, on the seventh day after you have executed this Release Agreement. You understand that if you revoke this Release Agreement, you will not be entitled to any severance benefits (to the extent not
already paid or provided) under your employment agreement with the Company. 
 (d) Counterparts. This Release Agreement
may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 *        *        *        *        *

  

	
	ACCEPTED AND AGREED:
	
	/s/ Cavan M. Redmond
	Name: Cavan M. Redmond
	
	Dated: 7 May 2013

  
 A-3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}]]